Your institution may have access to this item. Find your institution then sign in to continue.
Title
Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.
Authors
Hotho DM; de Bruijne J; Spaan M; Treitel MA; Boonstra A; de Knegt RJ; Janssen HL; Reesink HW
Publication
Journal of viral hepatitis, 2013, Vol 20, Issue 4, pe78